Alan J. Main, Ph.D.

Alan J. Main, Ph.D.

Executive Vice President, Innovation and Chemical SciencesatLexicon Pharmaceuticals· In proxies 2021–2024

Pay in FY2024+1% from the year before · Lexicon Pharmaceuticals stock -51.7% the same year

Alan J. Main, Ph.D. was paid $1.4M in FY2024 (Dec), up 1%. Lexicon Pharmaceuticals stock fell 51.7% that year.

Pay$100 in the stock at the end of FY20 → $22
Pay is from the Summary Compensation Table of each Lexicon Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lexicon PharmaceuticalsPublic company · 5 yr
    • Executive Vice President, Innovation and Chemical Sciences2021 – Present · 5 yrStock in role -57%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?